INVEST Feasibility - Minimally Invasive Endoscopic Surgery With Apollo in Patients With Brain Hemorrhage

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2017

Primary Completion Date

September 7, 2022

Study Completion Date

September 7, 2022

Conditions
Intracranial Hemorrhage
Interventions
DEVICE

Apollo MIES

Subjects will receive best medical management plus MIES (minimally invasive endoscopic surgery with use of the Apollo System.

OTHER

Medical Management

Subjects will receive best medical management for intracranial hemorrhage

Trial Locations (7)

10029

Icahn School of Medicine at Mount Sinai, New York

14260

University of Buffalo, Buffalo

17822

Geisinger Medical Center, Danville

20037

George Washington University, Washington D.C.

29601

Prisma Health, Greenville

40202

University of Louisville, Louisville

98195

University of Washington, Seattle

All Listed Sponsors
collaborator

MOUNT SINAI HOSPITAL

OTHER

collaborator

University at Buffalo

OTHER

lead

J. Mocco

OTHER

NCT02654015 - INVEST Feasibility - Minimally Invasive Endoscopic Surgery With Apollo in Patients With Brain Hemorrhage | Biotech Hunter | Biotech Hunter